Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. BIIB
7. CMG
8. TENB
9. KLAC
10. ETSY

Go back to Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 17c

Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2019 Financial Results

November 5, 2019 7:30 AM EST

NEW YORK, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today provided a corporate update and announced its financial results for the third quarter ended September 30, 2019.

I am pleased with the significant progress we have made in the third quarter across our commercial, regulatory, and clinical initiatives, said Dr. Sharon Mates, Chairman and CEO of Intra-Cellular Therapies. We... More